HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $842 | +5.2% | 9,395 | 0.0% | 0.01% | +25.0% |
| Q2 2023 | $800 | +3.0% | 9,395 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $777 | +5.1% | 9,395 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $739 | -99.9% | 9,395 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $696,000 | +13.7% | 9,395 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $612,000 | +3.0% | 9,395 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $594,000 | +19.3% | 9,395 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $498,000 | -24.9% | 9,395 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $663,000 | +5.9% | 9,395 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $626,000 | -36.6% | 9,395 | +5.6% | 0.00% | -50.0% |
| Q1 2021 | $987,000 | -6.5% | 8,895 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $1,056,000 | +36.1% | 8,895 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $776,000 | -51.3% | 8,895 | -50.0% | 0.01% | -14.3% |
| Q2 2020 | $1,594,000 | – | 17,790 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |